News

Overview of RNA Therapeutics MarketThe Global RNA Therapeutics Market is valued at USD 10.9 Billion in 2024 and is projected ...
Trump hopes to slash the NIH budget by 38%, or almost $18bn; cut NSF budget by $4.7bn, more than 50%, scrap nearly half of ...
Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.
The MAHA movement has scored major wins in recent weeks, including on food dyes and vaccine recommendations but has also seen ...
A precipitation-based chromatography alternative, a novel viral vector isolation tech, and a glycosylation prediction system are among the projects awarded funding in the latest round of grants issued ...
SWEATING THE MAHA REPORT — A report expected today from Robert F. Kennedy Jr. on childhood chronic diseases could spark ...
Moderna's advanced logistics tech tackles temperature challenges, minimizes shipping risks, and ensures critical medical products reach their destination safely.
Somatic hypermutation (SHM) of immunoglobulin variable (V) regions modulates antibody-antigen affinity is initiated by activation-induced cytidine deaminase (AID) on single-stranded DNA (ssDNA).
Alongside its expansion into low-scale oligo synthesis, the company has rebranded its custom oligos to better target ...
ASML’s new $400 million chip colossus transforms how semiconductors are made. CNBC got the first-ever on-camera look at the new machine, called High NA.